Literatur
- 1
Reinhold-Keller E, Beuge N, Latza U, de Groot K, Rudert H, Nölle B, Heller M, Gross W L.
An interdisciplinary
approach to the care of patients with Wegener’s granulomatosis:
long-term outcome in 155 patients.
Arthritis Rheum.
2000;
43
1021-1032
- 2
Hoffman G S, Kerr G S, Leavitt R Y, Hallahan C W, Lebovics R S, Travis W D, Rottem M,
Fauci A S.
Wegener’ granulomatosis:
an analysis of 158 patients.
Ann Intern Med.
1992;
116
488-498
- 3
Jayne D RW, Rasmussen N. for the European Community
Systemic Vasculitis Clinical Trials Study Group .
Treatment
of antineutrophil cytoplasm autoantibody-associated systemic vasculitis:
initiatives of the European Community Systemic Vasculitis Clinical
Trials Study Group.
Mayo Clin Proc.
1997;
72
737-747
- 4
Jayne D, Gaskin D. for EUVAS .
Randomized
trial of cyclophosphamide versus azathoioprine during remission
in ANCA-associated vasculitis (CYCAZAREM).
J Am Soc Nephrol.
1999;
10
105A
- 5
Metzler C, Fink C, Lamprecht P, Gross W L, Reinhold-Keller E.
Successful
Maintenance of Remission with Leflunomide in Wegener’s
Granulomatosis.
Arthritis Rheum.
2002;
(submitted)
- 6
Reinhold-Keller E, Fink C OE, Herlyn H, Gross W L, de Groot K.
High
rate of renal relapses in 71 patients with Wegener’s granulomatosis
under maintenance of remission with low-dose methotrexate.
Arthritis
Rheum.
2002;
47(3)
326-332
- 7
Langford C A, Talar-Williams C, Barron K S, Sneller M C.
A
staged approach to the treatment of Wegener’s granulomatosis.
Induction of remission with glucocorticoids and daily cyclophosphamide
switching to methotrexate for remission maintenance.
Arthritis
Rheum.
1999;
42
2666-2673
Autor
Dr. Eva Reinhold-Keller
Prof. Dr. Wolfgang L. Gross
Poliklinik für Rheumatologie, Universitätsklinikum
zu Lübeck
Ratzeburger Allee 160
23538
Lübeck
